Treatment options for diffuse diabetic macular edema
- PMID: 23264328
- DOI: 10.5301/EJO.2010.6054
Treatment options for diffuse diabetic macular edema
Abstract
Purpose: To describe the current management of diffuse diabetic macular edema (DDME).
Methods: Review and discussion of the literature regarding DDME.
Results: Diffuse diabetic macular edema is a condition that can be managed by means of several treatment options, including focal/grid laser photocoagulation, intravitreal or periocular corticosteroids, intravitreal anti-vascular endothelial growth factor (VEGF), and vitrectomy with or without internal limiting membrane peeling.
Conclusions: Even though there is no randomized clinical trial specifically designed to assess the best treatment approach for DDME, new therapeutic approaches based on intravitreal injections of corticosteroid and anti-VEGF molecules offer new hope for its management.
Similar articles
-
Intravitreal injections and diabetic macular edema: actual and new therapeutic options.Curr Diabetes Rev. 2013 Nov;9(6):491-8. doi: 10.2174/15733998113096660083. Curr Diabetes Rev. 2013. PMID: 24160355 Review.
-
Current treatment approaches in diabetic macular edema.Ophthalmologica. 2007;221(2):118-31. doi: 10.1159/000098257. Ophthalmologica. 2007. PMID: 17380066 Review.
-
Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.Jpn J Ophthalmol. 2017 Jan;61(1):51-60. doi: 10.1007/s10384-016-0483-8. Epub 2016 Oct 11. Jpn J Ophthalmol. 2017. PMID: 27730425 Clinical Trial.
-
How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema?Acta Ophthalmol. 2019 Jun;97(4):339-346. doi: 10.1111/aos.13997. Epub 2018 Dec 21. Acta Ophthalmol. 2019. PMID: 30575304 Review.
-
Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.Retina. 2013 Feb;33(2):403-13. doi: 10.1097/IAE.0b013e3182695b83. Retina. 2013. PMID: 23222389
Cited by
-
The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.Dtsch Arztebl Int. 2012 Sep;109(37):584-90. doi: 10.3238/arztebl.2012.0584. Epub 2012 Sep 14. Dtsch Arztebl Int. 2012. PMID: 23093988 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical